<VariationArchive VariationID="590846" VariationName="NM_000321.3(RB1):c.371_372del (p.Ile124fs)" VariationType="Deletion" Accession="VCV000590846" Version="10" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-02" DateCreated="2018-11-25" MostRecentSubmission="2024-06-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="581784" VariationID="590846">
      <GeneList>
        <Gene Symbol="RB1" FullName="RB transcriptional corepressor 1" GeneID="5925" HGNC_ID="HGNC:9884" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="48303751" stop="48481890" display_start="48303751" display_stop="48481890" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48877882" stop="49056025" display_start="48877882" display_stop="49056025" Strand="+" />
          </Location>
          <OMIM>614041</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000321.3(RB1):c.371_372del (p.Ile124fs)</Name>
      <CanonicalSPDI>NC_000013.11:48342703:ATA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="48342704" stop="48342705" display_start="48342704" display_stop="48342705" variantLength="2" positionVCF="48342703" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48916840" stop="48916841" display_start="48916840" display_stop="48916841" variantLength="2" positionVCF="48916839" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>I124fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.48916841_48916842del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.48916841_48916842del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.48342705_48342706del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.48342705_48342706del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009009.1" sequenceAccession="NG_009009" sequenceVersion="1" change="g.43959_43960del">
            <Expression>NG_009009.1:g.43959_43960del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000321.3" sequenceAccession="NM_000321" sequenceVersion="3" change="c.371_372del" MANESelect="true">
            <Expression>NM_000321.3:c.371_372del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000312.2" sequenceAccession="NP_000312" sequenceVersion="2" change="p.Ile124fs">
            <Expression>NP_000312.2:p.Ile124fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_517" sequenceAccession="LRG_517">
            <Expression>LRG_517:g.43959_43960del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000321.2" sequenceAccession="NM_000321" sequenceVersion="2" change="c.371_372delTA">
            <Expression>NM_000321.2:c.371_372delTA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000321.2" sequenceAccession="NM_000321" sequenceVersion="2" change="c.371_372del">
            <Expression>NM_000321.2:c.371_372del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_517t1" sequenceAccession="LRG_517t1">
            <Expression>LRG_517t1:c.371_372del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1566186125" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000321.3(RB1):c.371_372del (p.Ile124fs) AND Retinoblastoma" Accession="RCV000722028" Version="4">
        <ClassifiedConditionList TraitSetID="3557">
          <ClassifiedCondition DB="MedGen" ID="C0035335">Retinoblastoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-05-20" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000321.3(RB1):c.371_372del (p.Ile124fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV001020949" Version="3">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-08-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000321.3(RB1):c.371_372del (p.Ile124fs) AND not provided" Accession="RCV003226972" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000321.3(RB1):c.371_372del (p.Ile124fs) AND RB1-related disorder" Accession="RCV003983181" Version="1">
        <ClassifiedConditionList TraitSetID="89988">
          <ClassifiedCondition>RB1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-05-20" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2018-11-25" MostRecentSubmission="2024-06-02">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17096365</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22219649</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25754945</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29568217</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8217609</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3557" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6463" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RETINOBLASTOMA, SOMATIC</ElementValue>
                <XRef Type="Allelic variant" ID="614041.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Retinoblastoma</ElementValue>
                <XRef ID="2161" DB="GeneTests" />
                <XRef ID="Retinoblastoma/6282" DB="Genetic Alliance" />
                <XRef ID="HP:0009919" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008380" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eye cancer, retinoblastoma</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RB1</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RB</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000333054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502480" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000324949" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502479" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521663" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500108" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000597429" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501237" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518780" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500594" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502581" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Both sporadic and heritable forms are tested.</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors.</Attribute>
                <XRef ID="NBK1452" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7563" />
                <XRef ID="7563" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301625</ID>
                <ID Source="BookShelf">NBK1452</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 1995">
                <ID Source="pmc">1801355</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">3061998</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 2015">
                <ID Source="PubMed">26140447</ID>
                <ID Source="pmc">4570999</ID>
              </Citation>
              <XRef ID="790" DB="Orphanet" />
              <XRef ID="C0035335" DB="MedGen" />
              <XRef ID="D012175" DB="MeSH" />
              <XRef ID="MONDO:0008380" DB="MONDO" />
              <XRef Type="MIM" ID="180200" DB="OMIM" />
              <XRef Type="primary" ID="HP:0009919" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89988" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71389" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">RB1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RB1-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1663698" SubmissionDate="2018-08-09" DateLastUpdated="2018-11-25" DateCreated="2018-11-25">
        <ClinVarSubmissionID localKey="NM_000321.2:c.371_372delTA|MedGen:C0035335" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000853205" DateUpdated="2018-11-25" DateCreated="2018-11-25" Type="SCV" Version="1" SubmitterName="St. Jude Molecular Pathology, St. Jude Children's Research Hospital" OrgID="506672" OrganizationCategory="laboratory" OrgAbbreviation="SJCRH-MP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This is a frameshift alteration in which a TA is deleted at coding nucleotides 371-372 and is predicted to change an Isoleucine to an Arginine at amino acid codon 124, shift the reading frame and result in a premature stop codon 6 amino acids downstream. Classification criteria: PVS1, PS3, PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.2:c.371_372delTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Retinoblastoma</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0035335" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4387139</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2322487" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="a512246|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001182497" DateUpdated="2024-05-01" DateCreated="2020-03-16" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.371_372delTA pathogenic mutation, located in coding exon 3 of the RB1 gene, results from a deletion of two nucleotides at nucleotide positions 371 to 372, causing a translational frameshift with a predicted alternate stop codon (p.I124Rfs*6). This mutation has been detected in multiple individuals with unilateral and bilateral retinoblastoma (Onadim et al. Br. J. Cancer 1993 Nov;68(5):958-64; Abidi et al. Mol. Vis. 2011 Dec;17:3541-7; Sagi et al. Fam. Cancer 2015 Sep;14(3):471-80; Li et al. Int J Clin Exp Pathol 2016;9(2):2120-2126; Meng et al. Zhonghua Yan Ke Za Zhi 2017 Jun;53(6):455-459; Nguyen et al. Mol. Vis. 2018 Mar;24:231-238). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.2:c.371_372delTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7335261" SubmissionDate="2023-05-10" DateLastUpdated="2023-05-13" DateCreated="2023-05-13">
        <ClinVarSubmissionID localKey="GDXSV:270917" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003923965" DateUpdated="2023-05-13" DateCreated="2023-05-13" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 8217609, 29568217, 34190019, 28606269)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:649896</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.2:c.371_372del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_190_20230510054202</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7981773" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4913953|MedGen:C0035335" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004297209" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17096365</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8217609</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22219649</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25754945</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29568217</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile124Argfs*6) in the RB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with bilateral retinoblastoma and retinoblastoma (PMID: 8217609, 22219649, 25754945, 29568217). In at least one individual the variant was observed to be de novo. This variant is also known as c.371_372delTA. ClinVar contains an entry for this variant (Variation ID: 590846). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.48916840_48916841del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0035335" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8882293" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="40597924|RB1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004800238" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The RB1 c.371_372delTA variant is predicted to result in a frameshift and premature protein termination (p.Ile124Argfs*6). This variant was reported in multiple individuals with RB1 related disorders, and has been documented as a de novo findings (Nguyen et al. 2018. PubMed ID: 29568217; Fang et al. 2021. PubMed ID: 34190019). This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in RB1 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.2:c.371_372delTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">RB1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9794956" SubmissionDate="2024-05-29" DateLastUpdated="2024-06-02" DateCreated="2024-06-02">
        <ClinVarSubmissionID localKey="NM_000321.3:c.371_372del|OMIM:180200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005046372" DateUpdated="2024-06-02" DateCreated="2024-06-02" Type="SCV" Version="1" SubmitterName="Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine" OrgID="1224" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-05-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Case and Pedigree Information: BILATERAL CASES:1, UNILATERAL CASES:0, TOTAL CASES:1, PEDIGREES:1. ACMG Codes Applied:PVS1, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.3:c.371_372del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="180200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>RB12024</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7335261" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2322487" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9794956" TraitType="Disease" MappingType="XRef" MappingValue="180200" MappingRef="OMIM">
        <MedGen CUI="C0035335" Name="Retinoblastoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7981773" TraitType="Disease" MappingType="XRef" MappingValue="C0035335" MappingRef="MedGen">
        <MedGen CUI="C0035335" Name="Retinoblastoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1663698" TraitType="Disease" MappingType="Name" MappingValue="Retinoblastoma" MappingRef="Preferred">
        <MedGen CUI="C0035335" Name="Retinoblastoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8882293" TraitType="Disease" MappingType="Name" MappingValue="RB1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="RB1-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

